The design of a decision aid about diabetes medications for use during the consultation with patients with type 2 diabetes.

OBJECTIVE To describe the process used to develop a medication choice decision aid (DA) for patients with type 2 diabetes. METHODS We developed the DA through active collaboration with patients, clinicians, and designers, direct observations of clinical encounters, literature review, and collaborative development of design criteria. Insights from these processes informed the iterative creation of prototypes that were reviewed and field tested in actual consultations. RESULTS The goal of the DA was to facilitate a conversation between the clinician and the patient about diabetes medication options. Four iterations of the DA were developed and field-tested before arriving at issue cards that organized the data for five medications around glucose control, hypoglycemia, weight changes, daily routine, self-monitoring and side effects. These cards successfully generated conversations during consultations. An ongoing clinical trial will determine if this DA affects patient adherence and outcomes. CONCLUSIONS A collaboratively developed DA designed to create a conversation about diabetes medications may lead to more patient-centered treatment choices. PRACTICE IMPLICATIONS If effective, this DA could replace disease-centered treatment algorithms for patient-centered conversations that enhance the management of patients with type 2 diabetes.

[1]  B. Zinman,et al.  Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy , 2006, Diabetes Care.

[2]  G. Guyatt,et al.  Patient-important outcomes in diabetes—time for consensus , 2007, The Lancet.

[3]  Amiram Gafni,et al.  A shared treatment decision‐making approach between patients with chronic conditions and their clinicians: the case of diabetes , 2006, Health expectations : an international journal of public participation in health care and health policy.

[4]  P. Cryer.  Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy: A Consensus Statement From the American Diabetes Association and the European Association for the Study of Diabetes , 2007, Diabetes Care.

[5]  Kevin B Weiss,et al.  Evaluating Physician Performance at Individualizing Care: A Pilot Study Tracking Contextual Errors in Medical Decision Making , 2007, Medical decision making : an international journal of the Society for Medical Decision Making.

[6]  Lynn Ordway,et al.  Antecedents of adherence to medical recommendations: Results from the medical outcomes study , 1992, Journal of Behavioral Medicine.

[7]  Brenda Laurel,et al.  Design Research: Methods and Perspectives , 2003 .

[8]  C. McHorney,et al.  Understanding Diabetes Medications From the Perspective of Patients With Type 2 Diabetes , 2006, The Diabetes educator.

[9]  R. Ryckman,et al.  Provider-patient interaction in diabetes care: effects on patient self-care and outcomes. A systematic review. , 2003, Patient education and counseling.

[10]  Mike Walsh,et al.  Action Research—a Necessary Complement to Traditional Health Science? , 2008, Health Care Analysis.

[11]  P. Ubel,et al.  Rethinking the Objectives of Decision Aids: A Call for Conceptual Clarity , 2007, Medical decision making : an international journal of the Society for Medical Decision Making.

[12]  A. O'Connor.  Using decision aids to help patients navigate the “grey zone” of medical decision-making , 2007, Canadian Medical Association Journal.

[13]  B. Zinman,et al.  Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy , 2009, Diabetes Care.

[14]  Glyn Elwyn,et al.  Development of an information source for patients and the public about general practice services: an action research study , 2006, Health expectations : an international journal of public participation in health care and health policy.

[15]  C. Charles,et al.  Treatment decision aids: conceptual issues and future directions , 2005, Health expectations : an international journal of public participation in health care and health policy.

[16]  Executive Summary: Standards of Medical Care in Diabetes—2009 , 2009, Diabetes Care.

[17]  Aileen Clarke,et al.  Developing a quality criteria framework for patient decision aids: online international Delphi consensus process , 2006, BMJ : British Medical Journal.

[18]  [Management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy. (A consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes)]. , 2007, Problemy endokrinologii.

[19]  David O. Meltzer,et al.  Patient Perceptions of Quality of Life With Diabetes-Related Complications and Treatments , 2007 .

[20]  C. Charles,et al.  Lessons learned from the Decision Board: a unique and evolving decision aid , 2000, Health expectations : an international journal of public participation in health care and health policy.

[21]  S. Weiner.  Contextualizing medical decisions to individualize care: lessons from the qualitative sciences. , 2004, Journal of general internal medicine.

[22]  Richard W Grant,et al.  How Doctors Choose Medications to Treat Type 2 Diabetes , 2007, Diabetes Care.

[23]  Shari Bolen,et al.  Systematic Review: Comparative Effectiveness and Safety of Oral Medications for Type 2 Diabetes Mellitus , 2007, Annals of Internal Medicine.

[24]  Dylan M. Smith,et al.  The relative importance of physician communication, participatory decision making, and patient understanding in diabetes self-management , 2002, Journal of General Internal Medicine.

[25]  J. Pugh,et al.  Attitudes of Primary Care Providers Toward Diabetes: Barriers to guideline implementation , 1998, Diabetes Care.

[26]  R. Thomson,et al.  Decision aids for people facing health treatment or screening decisions. , 2003, The Cochrane database of systematic reviews.